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Translational Benefit: Ultrashort Peptides
• Successful in producing a series peptide sequences of that 
self-assemble to form hydrogels or nanotubes in response to 
physiological stimuli
• Ultrashort  peptides (< 7 amino acids) → More cost effective
→ Upscale by Pharmaceutical Industry → Increased 
translational potential → Patient benefit
• Numerous advantages over current synthetic materials 
including:
• Increased chemical versatility 
• Minimal immunogenicity and enhanced biocompatibility
• Tunable biodegradability 
• Tailored self-assembly/pharmacological properties (e.g. 
antimicrobial) in response to stimuli 
Rafferty,J., Nagaraj, H., McCloskey,A., Albadr, A., Huwaitat,R., Porter,S., *Laverty,G
(2016) Peptide therapeutics and the pharmaceutical industry: barriers encountered 
translating from the laboratory to patients. Current Medicinal Chemistry. 23(37): 4231-
4259
Rational Design of Antimicrobial Peptide 
Motif vs Self-assembly
Antimicrobial Activity Propensity to Self-assembled hydrogels
Hydrophobic/Hydrophilic (Charge) ratio 
(more important with regard to antimicrobial 
activity than size)
Hydrophobic/Hydrophilic balance
Interactions with microbial extracelluar
membranes
Non Covalent intermolecular interactions (e.g. 
Van der Waal’s, π-π stacking) 
Interaction with intracellular targets/processes 
(DNA, RNA, enzymes, protein synthesis). 
Binds to DNA, lipopolysaccharide to prevent pro-
inflammatory response = immunomodulatory 
Ability of peptide to form hydrogen bonds with 
each other and with water
McCloskey A.P., Gilmore, B.F., Laverty, G. (2014) Evolution of Antimicrobial 
Peptides to Self-Assembled Peptides for Biomaterial Applications. Pathogens. 
3(4); 791-821.
Biofunctional Nanomaterials utilising the 
building blocks of life!
Wound healing 
Stem Cells/Regenerative 
medicine
Infection and Medical 
Devices  
Drug Delivery
Low hanging fruit
Antimicrobial Resistance
• Biomaterial and wound 
infections
• Increased reservoir of 
“superbugs”
• Persistent burden on:
• Patient morbidity & mortality
• Family and carers
• Healthcare budgets
Cationic Naphthalene-diphenylalanine derivatives 
• Charge: Inclusion of cationic amino acids
– Lysine 
– Ornithine 
– epsilon (ε) Lysine
– Arginine….
• Minimum of 2 charged units required for antimicrobial activity
• Primary amine group provides cationic charge
• Cationic amino acids vary by number of methylene units on R-group = affects pKa = lysine greatest cationic charge at 
physiological pH
-Laverty, G., McCloskey A.P., Gilmore, B.F., Jones, D.S., Zhou, J., Xu, B (2014).  Ultrashort Cationic Naphthalene derived Self-assembled Peptides as 
Antimicrobial Nanomaterials. Biomacromolecules; 15: 3429−3439.
-Laverty, G., Gorman, S.P. and Gilmore, B.F (2012).  The Adherence of Staphylococcus epidermidis to Antimicrobial Peptide Incorporated poly(2-
hydroxyethyl methacrylate) Hydrogels.  Journal of Biomedical Materials Research: Part A 100A; 1803–1814.
Anti-biofilm activity
Percentage reduction of mature 24 hour Staphylococcus aureus (ATCC 29213) biofilm after 24 
hour incubation with peptide hydrogels utilizing an alamarBlue assay.  N= 8   
Laverty, G., McCloskey A.P., Gilmore, B.F., Jones, D.S., Zhou, J., Xu, B (2014). Biomacromolecules; 15: 3429−3439.
Biofilms and Implant-Associated Infections. Laverty, G., Gorman, 
S.P. and Gilmore, B.F. In: Biomaterials and Medical Device 
Associated Infections. Woodhead Publishing Ltd. 2014
SEM 
Pseudomonas 
aeruginosa, 
shown here 
attached to an 
implant surface, 
is one of many 
resistant 
microorganisms
Multifunctional NSAID-peptide hydrogels for the 
treatment of chronic wounds
• Chronic wounds: unable to heal fully or respond to 
treatment within 4 to 12 weeks. E.g. pressure wounds, 
diabetic ulcers, burn/surgical wounds.
• Latest UK estimates (2005-06), reported an incidence 
of 575,600 patients annually costing the NHS between 
£2.3 and 3.1billion, 3% of yearly healthcare 
expenditure. 
• Differ from acute wounds in that they are associated 
with prolonged inflammation that prevents healing 
fully: Non steroidal anti-inflammatory drugs (NSAIDs) 
showing benefit.
• Optimal multifunctional peptide: hydrogelating, 
biocompatible, antimicrobial, anti-inflammatory, pro-
angiogenic
Prevention better than cure!!
Figure 1. NSAID-peptide hydrogel mode of action, promoting healing of chronic wounds. a) Ease of administration: shear thinning hydrogel will flow upon administration via syringe and remain 
in situ within the varying shape of wound cavity. Held in place by a secondary dressing (e.g. Tegaderm). b) Antimicrobial activity conferred by a dilysine moiety lowering microbial burden. c) 
Keratinocyte and dermal fibroblast migration promoted by a heparin mimetic motif and the cell supporting nanofibrous hydrogel scaffold leading to reepithelialisation and wound closure. d)
Nanofibrous cationic sponge binds to biomolecules (DNA, LPS) reducing TLR activation and lowering inflammatory cell recruitment via NFκB and MAPK pathways. e) NSAID moiety inhibits 
phosphorylation of IκB by IKK kinases and prevents NFκB activation. Production of interleukins (ILs-6, 8 10) and TNF-α inhibited resulting in reduced inflammation. f) Selective COX-2 inhibition 
by NSAID-peptide will reduce scar tissue formation in chronic wounds. g) Increased angiogenesis due to recruitment and activation of vascular endothelial growth factor (VEGF), fibroblast 
growth factor-2 (FGF-2) and hepatocyte growth factor (HGF) by the heparin mimetic peptide motif.
Multifunctional NSAID-peptide hydrogels: Design
Naproxen
Ibuprofen
Indomethacin
McCloskey,A.P., Gilmore,S.M., Zhou, J., Draper,E.R., Porter,S., Gilmore, B.F., Xu, B., Laverty,G.* (2016). Self-assembling ultrashort NSAID-Peptide nanosponges: 
multifunctional antimicrobial and anti-inflammatory materials. RSC Advances. 6: 114738-114749.
Optimal multifunctional peptide: 
• Hydrogelating ✓
• Biocompatible ✓
• Antimicrobial ✓
• Anti-inflammatory/immunomodulatory 
• selective COX-2 inhibition     ✓
• inhibit NFκB
• inhibit toll-like receptors by binding to biomolecules (e.g. 
DNA, bacterial LPS)
• Pro-angiogenic (heparin mimetic motif)
Multifunctional NSAID-peptide hydrogels: 
Hydrogelating, Biocompatible 
Oscillatory frequency sweep 2% w/v NSAID-peptides. 
Key: black triangle: Gʹ IbuFFKK, white triangle: Gʺ 
IbuFFKK black circle: Gʹ IndFFKK, white circle: Gʺ 
IndFFKK, black square: Gʹ NpxFFKK, white square: Gʺ 
NpxFFKK.
Data relating to L-isomers of 2%w/v peptide. a) Npx-
FFKK-OH hydrogel. b) TEM showing Npx-FFKK-OH 
nanofibres. c) LIVE/DEAD assay, 500µM Npx-FFKK-OH 
with NCTC929 fibroblasts. 
McCloskey,A.P., Gilmore,S.M., Zhou, J., Draper,E.R., Porter,S., 
Gilmore, B.F., Xu, B., Laverty,G.* (2016). Self-assembling 
ultrashort NSAID-Peptide nanosponges: multifunctional 
antimicrobial and anti-inflammatory materials. RSC Advances. 6: 
114738-114749.
Multifunctional NSAID-peptide hydrogels: 
Biocompatible & COX-2 selective (anti-inflammatory)
Cell compatibility and COX inhibition of L-isomers of X-FFKK-OH peptides. Ibuprofen (Ibu), indomethacin (Ind) and Npx conjugated at X. a) >90% cell viability, NCTC929 fibroblasts, 24 hour 
exposure (alamar blue assay). Key: striped:IbuFFKK, white:IndFFKK, grey:NpxFFKK, ns:no significant difference compared to negative PBS control. b) IC50 NSAID-peptide and NSAIDs only, 
inhibition of COX-1 (black column) and COX-2 (white column). Selectivity (S)=COX-1:COX-2 ratio of IC50 values. Addition of FFKK-OH to NSAIDs increases IC50 values relative to NSAID only but 
significant inhibition is maintained within the µM range. NSAID-peptides possess increased COX-2 selectivity compared to NSAID only, which is promising for chronic wound therapy. COX-2 
selectivity highest for NpxFFKK-OH (S=2.78) therefore it is the most promising NSAID-peptide for reducing scar tissue formation in chronic wounds.{{2895 Wilgus,T.A. 2004}}
Multifunctional NSAID-peptide hydrogels: Anti-
biofilm/Antimicrobial
Bactericidal activity of NSAID-FFKK-OH. a) NpxFFKK-OH (2-0.5%w/v) shows >90% in 24 hour biofilms of S.aureus ATCC25923 (black column), 
S.epidermidis ATCC35984 (grey), E.coli ATCC11303 (striped) and P.aeruginosa PAO1 (white) after 24 hours (alamar blue assay). b) Log10 reduction in 
S.aureus viable count after 24 hours, NSAID-peptides (2-0.5%w/v). Key: striped column: IbuFFKK-OH, white: IndFFKK-OH, grey: NpxFFKK-OH, dotted 
line: PBS control. At least a 3 log10CFU/mL (99.9%) reduction in bacteria, employed as a threshold for efficacy was observed for all NSAID-peptides at 
concentrations ≥0.5% w/v compared to PBS control. A similar trend was demonstrated for NSAID-peptides against S.epidermidis, E.coli and 
P.aeruginosa. 
Biofilms Mixture of biofilms, surface attached and liquid (planktonic bacteria)
Multifunctional NSAID-peptide hydrogels: Proof of 
concept & Future Work
Addition of a short heparin-mimetic amino acid motif: ability to enhance cell migration and angiogenesis
Production of & affinity for VEGF, FGF2 
and HGF pro-angiogenic growth factors
i) release from HMEC1 cells: ELISA
ii) ELISA binding assay
iii) ITC
Cell migration (HaCaT & dermal 
fibroblast) 
i) wound migration assay 
ii) Boyden tube assay 
Angiogenesis/neovascularisation
i) tube formation assay
Reduction of pro-inflammatory TNF-α & 
interleukin expression by NFκB & MAPK 
i) IKK inhibition:↓NFκB: kinase assay (ADP-Glo)
ii) TLR inhibition:↓NFκB & ↓MAPK: incubate 
biomolecules (e.g. nucleotides, LPS) with 
RAW264.7 macrophages. Measure ILs-6, 8 & 10, 
TNF-α by ELISA
iii) COX-1:COX-2 selectivity: COX inhibitor 
assay:IC50
Stability (proteases, pH, temperature)
37⁰C
25⁰C 
4⁰C 
D-peptide enantiomers: 
COX-2 selectivity 
can be increased 
20-fold by the use 
of D-peptide 
enantiomers*
*Li J., Gao Y., Kuang Y., Shi J., Du X., Zhou J., Wang H., Yang Z., Xu B. 
Dephosphorylation of D-peptide derivatives to form biofunctional, 
supramolecular nanofibers/hydrogels and their potential applications for 
intracellular imaging and intratumoral chemotherapy. J. Am. Chem. Soc. 
2013;135(26):9907–9914.
Wellcome Trust Research Fellow Opportunity 
• Novel Peptoid Hydrogels as Long Acting Injectable Drug Delivery Systems
• Experience in peptoid, peptidomimetic and peptide synthesis
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